RT Journal Article
SR Electronic
T1 Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8<sup>+</sup> T cell cytotoxicity over BEMPEG+RT
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004218
DO 10.1136/jitc-2021-004218
VO 10
IS 4
A1 Rolig, Annah S
A1 Rose, Daniel C
A1 McGee, Grace Helen
A1 Rubas, Werner
A1 Kivimäe, Saul
A1 Redmond, William L
YR 2022
UL http://jitc.bmj.com/content/10/4/e004218.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.